Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | AMGN | GILD | BIIB | CELG |
| Company | Dicerna Pharmaceutic | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 38.21 | 266.83 | 67.80 | 196.20 | 108.01 |
| High | 38.24 | 267.51 | 67.89 | 197.73 | 108.59 |
| Low | 38.21 | 263.81 | 67.18 | 194.94 | 107.27 |
| Last | 38.22 | 265.64 | 67.31 | 195.15 | 108.24 |
| Change | +0.22 | +0.13 | -0.44 | -1.65 | +0.11 |
| % Change | +0.58% | +0.05% | -0.65% | -0.84% | +0.10% |
| Volume | 5,568,900 | 2,017,500 | 4,974,900 | 871,900 | 191,230,496 |
| 20-Day Average Volume | 3,647,665 | 2,269,115 | 6,427,060 | 1,092,630 | 16,188,930 |
| Previous Close | 38.00 | 265.51 | 67.75 | 196.80 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 273.86 | 70.93 | 209.06 | 108.17 |
| 20-Day Raw Stochastic | 90.72% | 7.39% | 1.83% | 0.78% | 63.25% |
| 20-Day Relative Strength | 80.40% | 38.83% | 30.61% | 29.58% | 64.69% |
| Weighted Alpha | +35.17 | +5.85 | -23.45 | -36.64 | +46.30 |
| Today's Opinion | 88% Buy | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 72% Buy | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 24% Buy | 8% Sell | 72% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | -1.75% since 04/09/24 | -3.76% since 04/09/24 | -5.51% since 04/09/24 | -1.97% since 11/13/19 |
| Low | 37.81 on 12/21/21 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 194.94 on 04/16/24 | 107.27 on 11/20/19 |
| High | 38.24 on 12/27/21 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 205.24 on 04/12/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | -1.20% since 03/15/24 | -8.66% since 03/15/24 | -11.02% since 03/15/24 | +5.14% since 10/18/19 |
| Low | 37.78 on 12/10/21 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 194.94 on 04/16/24 | 102.40 on 10/21/19 |
| High | 38.26 on 12/03/21 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 221.74 on 03/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | -12.47% since 01/16/24 | -21.72% since 01/16/24 | -20.73% since 01/16/24 | +13.63% since 08/20/19 |
| Low | 19.06 on 10/06/21 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 194.94 on 04/16/24 | 93.41 on 08/23/19 |
| High | 38.26 on 12/03/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 252.17 on 01/22/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | -7.40% since 10/16/23 | -15.01% since 10/16/23 | -27.17% since 10/16/23 | +14.14% since 05/20/19 |
| Low | 19.06 on 10/06/21 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 194.94 on 04/16/24 | 89.08 on 07/23/19 |
| High | 40.14 on 07/20/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 269.43 on 10/17/23 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 142,291,856 | 84,353,968 | 28,607,044 | 77,035,920 |
| Shares Outstanding, K | 78,129 | 535,919 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 164,310,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -112,750,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 62,950,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -17,070,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 0.80 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 11/09/21 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 10.13 | 13.45 | 10.99 |